An oldie but a good one.... sort of paints the picture as to why CGS are chasing Clinical Trials.
Basic sums indicate that CGS are looking at $2000-2500 per person found suitable for trials
1191 trials that are said to be "relevant" to Cogstate.... over 450,000 subjects involved.
CGS very privileged to be included in the "A4 study".....
-----------------
Needs some FDA "device" approval news.... would very much like an update or how all that is traveling.
Could open the gateway to further dollars mentioned in slide below...
No doubt pharma wants to see new tools like Cogstate helping to streamline the recruitment process... "Each day of delay costs between $600K - $8M in foregone sales"
Market cap unsteady at present.... though most dregs are being collected by brokers at present. Illiquid as normal.....
Keep up the good work O'conner.
FDA.... FDA.... FDA.... an update please sir.
bsh
CGS Price at posting:
26.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)